This hypothesis is also supported by our results, indicating that patients with NAFLD and sarcopenia experience a worse metabolic condition, implied by the higher values of waist and hip circumferences, insulin levels, as well as HOMA-IR scores. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.